Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Constantinos A Demopoulos

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Mediators of Inflammation|February 7, 2008
Antithrombotic and antiatherosclerotic properties of olive oil and olive pomace polar extracts in rabbitsNektaria Tsantila, Haralabos C Karantonis, Despina N Perrea, et al.
European Journal of Anaesthesiology|May 5, 2009
Acetaminophen-induced liver injury and oxidative stress: protective effect of propofolGeorgia G Kostopanagiotou, Agni D Grypioti, Paraskevi Matsota, et al.
Lipids in Health and Disease|April 15, 2011
ATP-binding cassette transporter A1 gene polymorphisms and serum lipid levels in young Greek nursesVana Kolovou, Genovefa Kolovou, Apostolia Marvaki, et al.
Atherosclerosis|September 17, 2011
PAF effects on MCP-1 and IL-6 secretion in U-937 monocytes in comparison with oxLDL and IL-1β effectsSophia N Verouti, Elizabeth Fragopoulou, Haralabos C Karantonis, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 4, 2006
In vivo antiatherogenic properties of olive oil and its constituent lipid classes in hyperlipidemic rabbitsHaralabos C Karantonis, Smaragdi Antonopoulou, Despina N Perrea, et al.
AIDS Research and Human Retroviruses|July 16, 2008
Anti-platelet-activating factor effects of highly active antiretroviral therapy (HAART): a new insight in the drug therapy of HIV infection?Alexandros B Tsoupras, Maria Chini, Nickolaos Tsogas, et al.
AIDS Research and Human Retroviruses|November 5, 2011
Effects of HAART on platelet-activating factor metabolism in naive HIV-infected patients I: study of the tenofovir-DF/emtricitabine/efavirenz HAART regimenMaria Chini, Alexandros B Tsoupras, Nikos Mangafas, et al.
Journal of Lipid Research|March 25, 2010
Implication of lipoprotein associated phospholipase A2 activity in oxLDL uptake by macrophagesKonstantinos P Markakis, Maria K Koropouli, Stavroula Grammenou-Savvoglou, et al.
Angiology|September 28, 2011
Platelet-activating factor and its basic metabolic enzymes in blood of naive HIV-infected patientsAlexandros B Tsoupras, Maria Chini, Nikos Mangafas, et al.
Molecules (Basel, Switzerland)|October 14, 2023
First-Row Transition Metal Complexes Incorporating the 2-(2'-pyridyl)quinoxaline Ligand (pqx), as Potent Inflammatory Mediators: Cytotoxic Properties and Biological Activities against the Platelet-Activating Factor (PAF) and ThrombinAntigoni Margariti, Vasiliki D Papakonstantinou, George M Stamatakis, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Mediators of Inflammation|February 7, 2008
Antithrombotic and antiatherosclerotic properties of olive oil and olive pomace polar extracts in rabbitsNektaria Tsantila, Haralabos C Karantonis, Despina N Perrea, et al.
European Journal of Anaesthesiology|May 5, 2009
Acetaminophen-induced liver injury and oxidative stress: protective effect of propofolGeorgia G Kostopanagiotou, Agni D Grypioti, Paraskevi Matsota, et al.
Lipids in Health and Disease|April 15, 2011
ATP-binding cassette transporter A1 gene polymorphisms and serum lipid levels in young Greek nursesVana Kolovou, Genovefa Kolovou, Apostolia Marvaki, et al.
Atherosclerosis|September 17, 2011
PAF effects on MCP-1 and IL-6 secretion in U-937 monocytes in comparison with oxLDL and IL-1β effectsSophia N Verouti, Elizabeth Fragopoulou, Haralabos C Karantonis, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 4, 2006
In vivo antiatherogenic properties of olive oil and its constituent lipid classes in hyperlipidemic rabbitsHaralabos C Karantonis, Smaragdi Antonopoulou, Despina N Perrea, et al.
AIDS Research and Human Retroviruses|July 16, 2008
Anti-platelet-activating factor effects of highly active antiretroviral therapy (HAART): a new insight in the drug therapy of HIV infection?Alexandros B Tsoupras, Maria Chini, Nickolaos Tsogas, et al.
AIDS Research and Human Retroviruses|November 5, 2011
Effects of HAART on platelet-activating factor metabolism in naive HIV-infected patients I: study of the tenofovir-DF/emtricitabine/efavirenz HAART regimenMaria Chini, Alexandros B Tsoupras, Nikos Mangafas, et al.
Journal of Lipid Research|March 25, 2010
Implication of lipoprotein associated phospholipase A2 activity in oxLDL uptake by macrophagesKonstantinos P Markakis, Maria K Koropouli, Stavroula Grammenou-Savvoglou, et al.
Angiology|September 28, 2011
Platelet-activating factor and its basic metabolic enzymes in blood of naive HIV-infected patientsAlexandros B Tsoupras, Maria Chini, Nikos Mangafas, et al.
Molecules (Basel, Switzerland)|October 14, 2023
First-Row Transition Metal Complexes Incorporating the 2-(2'-pyridyl)quinoxaline Ligand (pqx), as Potent Inflammatory Mediators: Cytotoxic Properties and Biological Activities against the Platelet-Activating Factor (PAF) and ThrombinAntigoni Margariti, Vasiliki D Papakonstantinou, George M Stamatakis, et al.
Pageof 6